Currier Rebrands to Alentra to Signal Growth
The manufacturer is shifting its identity to reflect a new focus on full-service healthcare development and production.
Updated on Oct. 27, 2026 in Healthcare
Live Poll
Do you trust that corporate rebranding efforts signal better service for the average customer?
Contract manufacturing firm Currier has officially rebranded as Alentra. The change marks the company's evolution from a specialized plastics producer into a comprehensive healthcare CDMO.
Why it matters
The rebrand highlights a shift in corporate strategy as the company integrates new service offerings to support medical device and pharmaceutical clients. It positions the firm as a full-service partner for product design, prototyping, and assembly.
The company has integrated multiple development, engineering, and manufacturing organizations over the past two years. This transition follows the previous acquisitions of Springboard Manufacturing and MOS Plastics.
The players
Alentra
Formerly known as Currier, this contract development and manufacturing organization provides services to the pharmaceutical and medical device industries.
Springboard Manufacturing
This entity is a manufacturing company that was acquired by Currier to help expand its production capabilities.
MOS Plastics
This company previously focused on plastics manufacturing before being acquired as part of the firm's broader integration strategy.
The details
The new identity reflects the company's expansion into product design, prototyping, and assembly services for the medical device, diagnostic, and pharmaceutical markets. By acquiring several California-based manufacturing businesses, the organization has significantly broadened its operational footprint.
Timeline
The rebranding to Alentra was formally announced on October 27, 2026.
The integration of engineering and manufacturing organizations occurred across 2025 and 2026.
Market Landscape
Alentra's transition follows the industry-wide trend of legacy plastics manufacturers pivoting into full-service healthcare CDMOs. This move allows the company to compete more aggressively against integrated product development and manufacturing rivals.
Clients in the medical device and pharmaceutical sectors can expect a more consolidated approach to product development and assembly under the new brand. The move centralizes design and manufacturing resources, potentially streamlining supply chains for healthcare partners.
The takeaway
Rebranding efforts often signal a firm's shift from commodity production toward higher-value specialized services. Business leaders looking to scale should consider how integrating niche acquisitions can transform their company's core value proposition.
Further reading
Learn more about the evolving landscape of medical production in the California Healthcare section.
Source note: This article includes information reported by PlasticsToday.
Live Poll
Do you trust that corporate rebranding efforts signal better service for the average customer?
